Is Magnesium Migraine Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Magnesium Migraine Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Sex-specific management of migraine a systematic review and consensus statement from the European Headache Federation (EHF). [Braca S (2026); evidence level 1] - 1 2 3 4 5 Migraine is a chronic, disabling neurovascular disorder characterized by recurrent episodes of moderate-to-severe headache, typically unilateral and pulsating in quality, and frequently associated with nausea, vomiting, photophobia, and phonophobia. [Santangelo Domenico (2026); evidence level 3] - These processes result in peripheral and central sensitization of nociceptive pathways, thereby amplifying pain perception and contributing to migraine chronicization []. [Santangelo Domenico (2026); evidence level 3] - 6 7 6 8 9 10 11 A growing body of evidence indicates that patients with migraine show impaired energy metabolism and reduced metabolic flexibility []. [Santangelo Domenico (2026); evidence level 3] - In approximately one-third of patients, migraine attacks are preceded or accompanied by transient focal neurological symptoms, known as aura, which most frequently manifests as visual disturbances but may also involve sensory, language, or motor symptoms []. [Santangelo Domenico (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.